First Mercantile Trust’s Quest Diagnostics DGX Stock Holding History

First Mercantile Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$240K	Sell	1,648 -42	-2%	-$6.14K	0.03%	350
2021 Q2	$223K	Sell	1,690 -176	-9%	-$23K	0.03%	400
2021 Q1	$240K	Buy	1,866 +1,466	+367%	+$181K	0.03%	366
2020 Q4	$48K	Buy	+400	New	+$48.8K	0.01%	787
2019 Q1	–	Sell	-230	Closed	-$19K	–	870
2018 Q4	$19K	Buy	230 +80	+53%	+$7.5K	﹤0.01%	860
2018 Q3	$16K	Sell	150 -20	-12%	-$2.19K	﹤0.01%	868
2018 Q2	$19K	Buy	+170	New	+$17.7K	﹤0.01%	887

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Mercantile Trust's DGX Position: Q3 2021 in Review

First Mercantile Trust reduced its Quest Diagnostics (DGX) stake by 2.5% in Q3 2021, selling an estimated $6.14K and leaving 1,648 shares worth $240K. The position accounts for 0.03% of the portfolio, ranked #350.

First Mercantile Trust first reported a position in DGX in Q2 2018 and has held it in 7 quarters since. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

First Mercantile Trust held 1,648 shares of Quest Diagnostics worth $240K as of Q3 2021.
First Mercantile Trust sold 42 Quest Diagnostics shares in Q3 2021, an estimated $6.14K.
Quest Diagnostics made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #350 holding.
First Mercantile Trust first reported a position in Quest Diagnostics in Q2 2018 and has held it in 7 quarters since.
837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.